Online delivery of oral HIV pre‐ and post‐exposure prophylaxis: findings from the ePrEP Kenya pilot
Journal of the International AIDS Society · 2025
DOI: 10.1002/jia2.26468 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Catherine Kiptinness und 24 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, Post-Exposure Prophylaxis, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Gates Foundation, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Introduction
The expansion of telecommunication networks and smartphones in many African countries could be leveraged to deliver HIV prevention products directly to consumers. In collaboration with a private e‐commerce platform and online pharmacy in Kenya, MYDAWA, we piloted a new model of HIV pre‐ and post‐exposure prophylaxis (PrEP/PEP) delivery.
Methods
In the ePrEP Kenya pilot (NCT05377138), individuals living in Nairobi and Mombasa Counties could complete a free telehealth visit with a remote clinician to assess eligibility for online PrEP/PEP (i.e. ≥18 years; no medical contraindications). Eligible individuals could order HIV testing services—courier delivered to clients’ choice location—for a fee of 250 KES (∼$2 USD) for self‐testing or 150 KES (∼$1 USD) for provider‐administered rapid diagnostic testing. Following confirmation of clients’ HIV‐negative status (via an uploaded test result image), free PrEP/PEP drugs from government supply were courier delivered with or separately from HIV testing services. Clients paid a delivery fee ≤149 KES (∼$1 USD) per courier visit.
Results
From October 2022 to December 2023, we screened 2257 individuals and enrolled 1915. Most PrEP/PEP clients were men (63%, 1428/1915), ≥25 years (72%, 1631/1915) and never married (80%, 1796/1915); few had ever used PrEP (3%, 48/1915) or PEP (14%, 263/1915). At enrolment, 227 (12%) were preliminarily eligible for PrEP and 1688 (88%) for PEP. Among PrEP‐eligible clients, 89% (203/227) completed HIV testing and 92% (208/227) received PrEP; among PEP‐eligible clients, 92% (1551/1688) completed HIV testing and 92% (1549/1688) received PEP. Most PrEP/PEP clients completed HIV testing within 6 hours of their telehealth visit (53%, 927/1757) and had drugs delivered with testing services (88%, 1546/1757). Among PrEP clients eligible for follow‐up, 47% (120/256) continued PrEP and 4% (10/256) initiated PEP following PrEP discontinuation. Among PEP clients eligible for follow‐up, 7% (99/1428) repeated PEP use and 6% (83/1428) transitioned from PEP to PrEP.).
Conclusions
Online PrEP/PEP delivery could expand access to prevention services by reaching individuals not engaged in existing delivery platforms. The uptake of online PEP was five times greater than PrEP, underscoring an unmet demand for PEP and highlighting the potential for online pharmacies to deliver time‐sensitive PEP services.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
- Department of Global Health, University of Washington, Seattle, Washington, USA.
- Department of Epidemiology, University of Washington, Seattle, Washington, USA.
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- MYDAWA, Nairobi, Kenya.
- Audere, Seattle, Washington, USA.
ORCID-Profile: Paulami Naik, Julia C Dettinger, Jillian Pintye, Melissa Latigo Mugambi, Daniel Were, Kenneth Ngure, Monisha Sharma, Katrina F Ortblad
Förderung
- NIMH NIH HHS
- Gates Foundation
- Bill and Melinda Gates Foundation
- National Institute of Mental Health
Zitieren
APA
Kiptinness, C., Naik, P., Kareithi, T., Thuo, N., Okello, P., Culquichicon, C., Rafferty, M., Abdulrashid, S., Jomo, E., Nyamasyo, N., Wood, T., Mendonca, R., Malen, R. C., Dettinger, J. C., Pintye, J., Mwangi, J., Stergachis, A., Onentia, J., Curran, K., …, & ePrEP Kenya team (2025). Online delivery of oral HIV pre‐ and post‐exposure prophylaxis: findings from the ePrEP Kenya pilot. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26468
Vancouver
Kiptinness C, Naik P, Kareithi T, Thuo N, Okello P, Culquichicon C, et al. Online delivery of oral HIV pre‐ and post‐exposure prophylaxis: findings from the ePrEP Kenya pilot. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.26468
BibTeX
@article{Kiptinness2025,
author = {Kiptinness, Catherine and Naik, Paulami and Kareithi, Tabitha and Thuo, Nicholas and Okello, Phelix and Culquichicon, Carlos and Rafferty, Maeve and Abdulrashid, Samira and Jomo, Edwin and Nyamasyo, Nicky and Wood, Tony and Mendonca, Rouella and Malen, Rachel C and Dettinger, Julia C and Pintye, Jillian and Mwangi, June and Stergachis, Andy and Onentia, Jonah and Curran, Kelly and Mugambi, Melissa Latigo and Were, Daniel and Ngure, Kenneth and Sharma, Monisha and Ortblad, Katrina F and ePrEP Kenya team, ePrEP Kenya team},
title = {Online delivery of oral HIV pre‐ and post‐exposure prophylaxis: findings from the ePrEP Kenya pilot},
journal = {Journal of the International AIDS Society},
year = {2025},
doi = {10.1002/jia2.26468}
}
EUVIMED